Cited by 18Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAdvanced Biosensing Techniques and Applications

Blood-based Alzheimer's disease diagnosis using fluorescent peptide nanoparticle arrays

Sun, Leming, Lei, Yang, Wang, Yuerong, Liu, Dingchang·2022·Chinese Chemical Letters

Integrity signals

Registry

Crossref · 10.1016/j.cclet.2021.10.071

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Protein nanoparticle surfaces have functional groups that make it simple to bind targeted ligands and other surface alterations as smart nanoparticles.

    “Protein nanoparticle surfaces have functional groups that make it simple to bind targeted ligands and other surface alterations as smart nanoparticles.56,59,60”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [59]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sun, L., Lei, Y., Wang, Y., & Liu, D.
Affiliations
Northwestern Polytechnical University (CN)
Corresponding author
Sun, Leming
Venue
Chinese Chemical Letters
Publisher
Elsevier BV
Published
2022-04
Volume
33
Issue
4
Pages
1946-1950
ISSN
1001-8417 (ISSN-L)
OpenAlex
W3210690355
Cited by
18
References
36
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 3
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Locations
Chinese Chemical Letters (publishedVersion)
Funders
  • National Natural Science Foundation of China (31900984)
  • China Postdoctoral Science Foundation (2018M631197)
  • Natural Science Foundation of Shaanxi Province (2019JQ-231)
  • Shaanxi Province Postdoctoral Science Foundation (2018BSHQYXMZZ42)
  • Fundamental Research Funds for the Central Universities (31020180QD063)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
Keywords
Alzheimer's disease diagnosis, blood-based biomarkers, tau protein, nanoparticle arrays, nanoparticle aggregation, Young's modulus, nanomechanical properties, disease progression monitoring, minimally invasive diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review